Search
for
Sort by
Research 271–300 of 1000+
- Hormonal Control of Cardiac Action Potential Phase 1 Currents in the Brugada Syndrome
- Dermatologic Reactions to Targeted Therapy
- Gender-Affirming Hormone Therapy for Transgender Females
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Testosterone therapy for transgender men
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Sertoli–Leydig cell tumors: hormonal profile after dynamic test with GnRH analogue: triptorelin represents a useful tool to evaluate tumoral hyperandrogenism
- Biological Investigation of Aqueous Extract of Funnel Seeds to Check its Therapeutic Effects in the Management of Polycystic Ovarian Syndrome in Induced PCOS Female Albino Rats
- A Clinical Evaluation of Guduchi (Tinospora cordifolia) and Yashtimadhu (Glycyrrhiza glabra) as Chemopreventive Agent in Cancer Treatment
- Microemulsions as Carriers for Therapeutic Molecules
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- The influence of cyclosporine A therapy on sex hormone levels in pre- and post-menopausal women with primary biliary cirrhosis
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Alopecia With Endocrine Therapies in Patients With Cancer
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- Table_2.docx
- Table_1.docx
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Flutamide
- Impact of conventional and advanced therapies in functional hair follicular regeneration in pesticide-induced hair loss: a Pharmacological perspective of review
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Male Sex Hormones in Andrology Today
- Clinical Snippets